Clinical Trial Update: Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients [NA]

View source ↗

Summary

A clinical trial update for NCT04222335 sponsored by University Hospital, Toulouse, currently recruiting to study early adaptive resistance to EGFR tyrosine-kin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Lung Cancer, Nonsmall Cell | NA | Status: RECRUITING